Concepedia

Christopher R. Herzog

CR

16

Publications

498

Citations

15

H-Index

1992

Active since

Affiliations

University of Toledo Medical Center(Current)

The Ohio State University

Institute for Cancer Prevention

Pennsylvania State University

National Institute of Environmental Health Sciences

Christopher R. Herzog is an author at University of Toledo Medical Center specializing in medicine, cell biology, and cancer genetics.

Top concepts

MedicineCell BiologyPathologyLung CancerTumor BiologyCancer GeneticsCancer ResearchCancer BiologyOncologyCell Death

Publications per year

1992–2010

16

Publications

16

Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.

Malisetty V. Swamy, Christopher R. Herzog, Chinthalapally V. Rao · PubMed · 2003 · 88 citations

Active P53, Chemoprevention Strategy, Pathology +17

Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats

Herman A.J. Schut, Christopher R. Herzog · Cancer Letters · 1992 · 62 citations

Biochemistry, Natural Sciences, Male Fischer-344 Rats +3

Genetic alterations in mouse lung tumors: Implications for cancer chemoprevention

Christopher R. Herzog, Ronald A. Lubet, Ming You · Journal of Cellular Biochemistry · 1997 · 61 citations

Lung Adenomas, Tumor Microenvironment, Oncogenic Agent +15

<i>FOXO3</i> Encodes a Carcinogen-Activated Transcription Factor Frequently Deleted in Early-Stage Lung Adenocarcinoma

Oliver R. Mikse, Daniel C. Blake, Nathan R. Jones et al. · Cancer Research · 2010 · 41 citations

Cell Death, Pathology, Cancer Biology +19

FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK)

Daniel C. Blake, Oliver R. Mikse, Willard M. Freeman et al. · Lung Cancer · 2009 · 27 citations

Pro-apoptotic Transcription Program, Oncogenic Agent, Cell Death +7

Rows per page

1–5 of 16